Hinxton, 27 March 2014 Where do you start when developing a new medicine? A pioneering public-private research initiative between GSK, the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute is to harness the power of ‘big data’ and genome sequencing to improve the success rate for discovering new medicines. The new Centre for Therapeutic Target Validation (CTTV) will aim to address a wide range of human diseases and will share its data openly in the interests of accelerating drug discovery.
Heidelberg, 7 March 2014 Slovak Republic becomes EMBL Prospect Member State EMBL welcomes the Slovak Republic as the first country to join its new Prospect Member scheme. In a Statement of Intent signed last month, the Slovak Republic and EMBL agree to explore the possibilities for long-term cooperation, with a view to the country becoming a full Member State within three years.
Heidelberg, 24 February 2014 Pan-European imaging infrastructure gains momentum Europe is uniting to make state-of-the-art imaging technologies accessible to biomedical researchers throughout the continent in a concerted manner. EMBL and seven countries have signed the Euro- BioImaging Memorandum of Understanding. In the coming months, the signatories will work together towards the implementation and construction of this new pan-European infrastructure for imaging technologies. All European countries are invited to participate and several European nations are already set to follow suit.
Monterotondo, 2 February 2014 Making your brain social Scientists have identified, for the first time, a way in which the decreased functional connectivity seen in the brain of many people with autism can come about: it can be caused by cells called microglia failing to trim connections between neurons, researchers from EMBL Monterotondo, the Istituto Italiano di Tecnologia and La Sapienza University demonstrate in a study published today in Nature Neuroscience.
Hamburg, 13 January 2014 Spearheading the study of infectious diseases Matthias Wilmanns, Head of EMBL Hamburg, has today been appointed founding director of the Centre for Structural Systems Biology (CSSB). At this interdisciplinary research centre, biologists, physicists and physicians will join forces, bringing together state-of-the-art structural biology, infection biology and systems biology approaches to investigate infectious diseases.
Heidelberg, 13 December 2013 Without rings, chromosome arms get broken You hop on the train, turn around to say goodbye, and the announcement sounds: ‘doors closing’. If you ignore the warning for the sake of one last wave to a friend on the platform, the doors may bruise you, but they won’t cut off your arm. Dividing yeast cells, are more ruthless, the Haering group at EMBL Heidelberg have discovered.
Heidelberg, 5 December 2013 Light at the ends of the tunnel When scientists in the Beck group at EMBL Heidelberg determined what one of the nuclear pore’s main building blocks – Nup107 – looks like and how it is arranged, they found clues to the flexibility of this tunnel into the nucleus. Their study was recently featured on the cover of Cell.